Abstract:The progression of clear cell renal cell carcinoma (ccRCC) remains a major challenge in clinical practice, and elucidation of the molecular drivers of malignancy progression is critical for the development of effective therapeutic targets. Recent studies have demonstrated that N6-methyladenosine (m6A) is the most abundant modification of eukaryotic mRNA and plays a key role in tumorigenesis and progression. However, the biological roles and underlying mechanisms of m6A-mediated autophagy in cancers especially in ccRCC remain poorly elucidated. m6A dot blot assay, m6A RNA methylation assay kit and immunofluorescence analysis were used to profile m6A levels in tissue samples and their correlation with autophagic flux. Expression patterns and clinical significance of fat mass and obesity-associated protein (FTO) were determined through bioinformatics analysis, real-time PCR, western blotting, immunohistochemistry. RNA-seq, MeRIP-seq, MeRIP-qRT-PCR, RIP-qRT-PCR, transmission electron microscopy, immunofluorescence analysis and luciferase reporter assay were used to investigate the underlying mechanism of the FTO-autophagy axis. The role of FTO and autophagy in ccRCC progression was evaluated both in vitro and in vivo. Here we found that m6A modification was suppressed and closely related to autophagic flux in ccRCC. Elevated FTO was inhibited by rapamycin, whereas silencing FTO enhanced autophagic flux and impaired ccRCC growth and metastasis. SIK2 was identified as a functional target of m6A-mediated autophagy, thereby prompting FTO to play a conserved and important role in inhibiting autophagy and promoting tumorigenesis through an m6A-IGF2BP2 dependent mechanism. Moreover, the small molecule inhibitor FB23-2 targeting FTO inhibited tumor growth and prolonged survival in the patient-derived xenograft (PDX) model mice, suggesting that FTO is a potential effective therapeutic target for ccRCC. Our findings uncovered the crucial role of FTO/autophagy/SIK2 axis in modulating the progression of ccRCC, suggesting that FTO may serve as a valuable prognostic biomarker and promising therapeutic target in ccRCC.

Autophagy induced by farnesyltransferase inhibitors in cancer cells.

Farnesyltransferase inhibitors-induced autophagy: alternative mechanisms?

Inhibition of autophagy potentiates the cytotoxicity of the irreversible FGFR1-4 inhibitor FIIN-2 on lung adenocarcinoma

Recent Advances in Understanding the Antineoplastic Mechanisms of Farnesyltransferase Inhibitors

FGF2/FGFR1 regulates autophagy in FGFR1-amplified non-small cell lung cancer cells

Autophagy Inhibition Promotes 5-Fluorouraci-induced Apoptosis by Stimulating ROS Formation in Human Non-Small Cell Lung Cancer A549 Cells.

Farnesyltransferase Inhibitors Induce Dna Damage Via Reactive Oxygen Species in Human Cancer Cells

Histone Deacetylase Inhibitors Induce Autophagy Through FOXO1-dependent Pathways.

FTO-mediated autophagy promotes progression of clear cell renal cell carcinoma via regulating SIK2 mRNA stability

Inhibition of fucoidan on breast cancer cells and potential enhancement of their sensitivity to chemotherapy by regulating autophagy

EGFR inhibitors and autophagy in cancer treatment

Inhibition of farnesyltransferase reduces angiogenesis by interrupting endothelial cell migration.

EGFR Tyrosine Kinase Inhibitors Activate Autophagy As a Cytoprotective Response in Human Lung Cancer Cells

Autophagy Contributes to Falcarindiol-Induced Cell Death in Breast Cancer Cells with Enhanced Endoplasmic Reticulum Stress

Akt Inhibition Attenuates Rasfonin-Induced Autophagy and Apoptosis Through the Glycolytic Pathway in Renal Cancer Cells

Autophagy-Dependent Ferroptosis in Cancer

Autophagic blockade potentiates anlotinib-mediated ferroptosis in anaplastic thyroid cancer

The Anti-Tumor Activity of Afatinib in Pancreatic Ductal Adenocarcinoma Cells

The Farnesyltransferase Inhibitor Lonafarnib Induces CCAAT/Enhancer-binding Protein Homologous Protein-dependent Expression of Death Receptor 5, Leading to Induction of Apoptosis in Human Cancer Cells

FTY720 Induces Necrotic Cell Death and Autophagy in Ovarian Cancer Cells: a Protective Role of Autophagy.